Jupiter Topco LLC Acquires New Stake in Inspire Medical Systems, Inc. $INSP

Jupiter Topco LLC purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 13,451 shares of the company’s stock, valued at approximately $601,000.

Several other institutional investors also recently modified their holdings of INSP. Royal Bank of Canada grew its position in Inspire Medical Systems by 16.0% in the first quarter. Royal Bank of Canada now owns 32,769 shares of the company’s stock worth $5,220,000 after acquiring an additional 4,528 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in Inspire Medical Systems during the first quarter worth about $524,000. Goldman Sachs Group Inc. boosted its holdings in shares of Inspire Medical Systems by 57.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 51,422 shares of the company’s stock worth $8,190,000 after purchasing an additional 18,857 shares in the last quarter. Marshall Wace LLP boosted its holdings in shares of Inspire Medical Systems by 3.8% in the 2nd quarter. Marshall Wace LLP now owns 15,905 shares of the company’s stock worth $2,064,000 after purchasing an additional 577 shares in the last quarter. Finally, Jump Financial LLC bought a new position in shares of Inspire Medical Systems during the 2nd quarter valued at about $931,000. 94.91% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

INSP has been the subject of a number of recent research reports. Robert W. Baird boosted their price objective on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. KeyCorp reissued a “sector weight” rating on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $60.00 price objective on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. Evercore set a $54.00 target price on Inspire Medical Systems in a research note on Tuesday, August 4th. Finally, Summit Redstone set a $39.00 price target on Inspire Medical Systems in a research note on Friday, May 22nd. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $66.19.

Inspire Medical Systems Price Performance

Shares of INSP opened at $62.99 on Monday. The company has a 50-day simple moving average of $55.05 and a two-hundred day simple moving average of $52.38. The firm has a market capitalization of $1.82 billion, a PE ratio of 13.63, a price-to-earnings-growth ratio of 4.79 and a beta of 0.70. Inspire Medical Systems, Inc. has a one year low of $38.91 and a one year high of $147.03.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The firm had revenue of $200.58 million during the quarter, compared to analyst estimates of $194.72 million. During the same quarter in the prior year, the company earned $0.45 EPS. The business’s revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Analysts expect that Inspire Medical Systems, Inc. will post 1.24 EPS for the current fiscal year.

Insider Transactions at Inspire Medical Systems

In related news, insider Jason Kelly sold 963 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the sale, the insider owned 18,985 shares of the company’s stock, valued at $1,130,556.75. This trade represents a 4.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is currently owned by insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.